Sökning: onr:"swepub:oai:DiVA.org:umu-144421" >
Antihypertensive tr...
-
Bang, Casper N.
(författare)
Antihypertensive treatment with β-blockade in patients with asymptomatic aortic stenosis and association with cardiovascular events
- Artikel/kapitelEngelska2017
Förlag, utgivningsår, omfång ...
-
Wiley-Blackwell Publishing Inc.2017
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:umu-144421
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-144421URI
-
https://doi.org/10.1161/JAHA.117.006709DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background: Patients with aortic stenosis (AS) often have concomitant hypertension. Antihypertensive treatment with a beta-blocker (Bbl) is frequently avoided because of fear of depression of left ventricular function. However, it remains unclear whether antihypertensive treatment with a Bbl is associated with increased risk of cardiovascular events in patients with asymptomatic mild to moderate AS.Methods and results: We did a post hoc analysis of 1873 asymptomatic patients with mild to moderate AS and preserved left ventricular ejection fraction in the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study. Propensity-matched Cox regression and competing risk analyses were used to assess risk ratios for all-cause mortality, sudden cardiac death, and cardiovascular death. A total of 932 (50%) patients received Bbl at baseline. During a median follow-up of 4.3 +/- 0.9 years, 545 underwent aortic valve replacement, and 205 died; of those, 101 were cardiovascular deaths, including 40 sudden cardiovascular deaths. In adjusted analyses, Bbl use was associated with lower risk of all-cause mortality (hazard ratio 0.5, 95% confidence interval 0.3-0.7, P<0.001), cardiovascular death (hazard ratio 0.4, 95% confidence interval 0.2-0.7, P<0.001), and sudden cardiac death (hazard ratio 0.2, 95% confidence interval 0.1-0.6, P=0.004). This was confirmed in competing risk analyses (all P<0.004). No interaction was detected with AS severity (all P>0.1).Conclusions: In post hoc analyses Bbl therapy did not increase the risk of all-cause mortality, sudden cardiac death, or cardiovascular death in patients with asymptomatic mild to moderate AS. A prospective study may be warranted to determine if Bbl therapy is in fact beneficial.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Greve, Anders M.
(författare)
-
Rossebø, Anne B.
(författare)
-
Ray, Simon
(författare)
-
Egstrup, Kenneth
(författare)
-
Boman, KurtUmeå universitet,Medicin(Swepub:umu)kubo0001
(författare)
-
Nienaber, Christoph
(författare)
-
Okin, Peter M.
(författare)
-
Devereux, Richard B.
(författare)
-
Wachtell, Kristian
(författare)
-
Umeå universitetMedicin
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Journal of the American Heart Association: Wiley-Blackwell Publishing Inc.6:122047-9980
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Bang, Casper N.
-
Greve, Anders M.
-
Rossebø, Anne B.
-
Ray, Simon
-
Egstrup, Kenneth
-
Boman, Kurt
-
visa fler...
-
Nienaber, Christ ...
-
Okin, Peter M.
-
Devereux, Richar ...
-
Wachtell, Kristi ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Journal of the A ...
- Av lärosätet
-
Umeå universitet